Vallon Pharmaceuticals, Inc.
2 clinical trials · Sponsor
◉ Watch Vallon Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR) (NCT04647903) | Vallon Pharmaceuticals, Inc. | 2020-10-05 |
| Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR) (NCT04232644) | Vallon Pharmaceuticals, Inc. | 2019-05-27 |
Track Vallon Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.